Ads

 

Ads

 

Ads

 

World Top 100 Healthcare Companies List by Market Cap in January 2024

World Top 100 Healthcare Companies List by Market Cap in January 2024, World Biggest 100 Healthcare Companies by Market Cap, World Largest 100 Healthcare Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Healthcare Companies in 2024
Metatag Abstract
World Top Healthcare Companies by Market Cap in 2024, World Top Healthcare Companies by Market Cap in 2024.
  1. Shanghai Kehua Bio-Engineering

    World Rank (Jan-05-2024)
    10,133
    Market Cap (Jan-05-2024)
    0.752 Billion USD
    World Rank (Jul-30-2023)
    10,578
    Market Cap (Jul-30-2023)
    0.713 Billion USD
    World Rank (Dec-25-2022)
    9,215
    Market Cap (Dec-25-2022)
    0.854 Billion USD
    World Rank (Jan-07-2022)
    8,379
    Market Cap (Jan-07-2022)
    1.23 Billion USD
    Headquarters Country
  2. Babylon Holdings Limited

    World Rank (Jan-05-2024)
    10,156
    World Rank (Jul-30-2023)
    10,156
    Market Cap (Jul-30-2023)
    0.768 Billion USD
    World Rank (Dec-25-2022)
    18,966
    Market Cap (Dec-25-2022)
    0.168 Billion USD
    Headquarters Country
  3. Retrophin

    World Rank (Jan-05-2024)
    10,171
    World Rank (Jul-30-2023)
    10,171
    World Rank (Dec-25-2022)
    10,171
    World Rank (Jan-07-2022)
    10,171
    Headquarters Country
    Company Profile
    Retrophin is a is a Biopharmaceutical company whose mission is to identify, develop and deliver life changing therapies to people living with rare disease. The company annual revenue is 185.3 million USD and 221 employees as on 2020. The headquarters is in USA.
  4. Polynovo

    World Rank (Jan-05-2024)
    10,178
    Market Cap (Jan-05-2024)
    0.747 Billion USD
    World Rank (Jul-30-2023)
    10,475
    Market Cap (Jul-30-2023)
    0.726 Billion USD
    World Rank (Dec-25-2022)
    8,983
    Market Cap (Dec-25-2022)
    0.891 Billion USD
    World Rank (Jan-07-2022)
    5,510
    Annual Revenue in USD
    16 Million USD
    Annual Net Income in USD
    -3 Million USD
    Annual Results for Period Ending
    Jun-2020 ending year
    Headquarters Country
    Company Profile

    Medical device company with headquarters is in Australia.

  5. Exscientia PLC

    World Rank (Jan-05-2024)
    10,187
    Market Cap (Jan-05-2024)
    0.745 Billion USD
    World Rank (Jul-30-2023)
    8,949
    Market Cap (Jul-30-2023)
    0.956 Billion USD
    World Rank (Dec-25-2022)
    11,931
    Market Cap (Dec-25-2022)
    0.537 Billion USD
    World Rank (Jan-07-2022)
    5,579
    Market Cap (Jan-07-2022)
    2.42 Billion USD
    Headquarters Country
    Company Profile
    Exscientia plc is a biotechnology company with automate drug design and are the first to have an AI Designed molecule enter clinical trials. The company annual revenue is 9.6 million GBP and total assets are 77.7 million GBP as on 2020. The headquarters is in UK.
  6. Jins Holdings

    World Rank (Jan-05-2024)
    10,197
    Market Cap (Jan-05-2024)
    0.744 Billion USD
    World Rank (Jul-30-2023)
    11,758
    Market Cap (Jul-30-2023)
    0.585 Billion USD
    World Rank (Dec-25-2022)
    9,682
    Market Cap (Dec-25-2022)
    0.787 Billion USD
    World Rank (Jan-07-2022)
    7,724
    Market Cap (Jan-07-2022)
    1.40 Billion USD
    Annual Revenue in USD
    466 Million USD
    Annual Net Income in USD
    24 Million USD
    Annual Results for Period Ending
    Aug-2021 ending year
    Headquarters Country
    Company Profile
    Jins Holdings business related to planning, manufacturing, sales and import / export of eyewear and fashion accessories. The company annual revenue is 63,898 million JPY and annual net income is 3,292 million JPY for year ending August 2021. The headquarters is in Japan.
  7. ACELYRIN Inc.

    World Rank (Jan-05-2024)
    10,200
    Market Cap (Jan-05-2024)
    0.744 Billion USD
    World Rank (Jul-30-2023)
    8,797
    Market Cap (Jul-30-2023)
    0.989 Billion USD
    Headquarters Country
    Company Profile
    ACELYRIN is a biopharma company that builds therapies and actively investigating the potential of izokibep and other programs in diseases where differentiated therapeutic approaches are required to address unmet patient needs. Headquarters is in USA.

Share

Ads